Spondyloarthritis & psoriatic arthritis

Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis

Rheumatology (Oxford)Published Cohort study

Authors' conclusion

Comorbidity burden, uveitis and psoriasis are independently associated with greater spinal radiographic progression in AS.

Study context

Population
AS fulfilling modified New York criteria with ≥1 lateral cervical or lumbar radiograph (mean age 44 years; 75% male; 84% HLA-B27 positive)3,441 patient-years analysed
Participants
1,150 participants
Exposure
Baseline comorbidity count and extra-musculoskeletal manifestations (EMMs) and spinal radiographic progression
Outcome
Spinal radiographic progression (mSASSS, range 0-48), mean difference in progression (units/10 years)
Methodological detailsgeneralized estimating equations, adjusted for baseline modified Stoke AS Severity Score (mSASSS), sex, symptom duration, CRP, HLA-B27, smoking, TNFi use, and number of EMMs or comorbidity count
  • Generalized estimating equations
  • Adjusted for baseline mSASSS, sex, symptom duration, CRP, HLA-B27, smoking, TNFi use, and number of EMMs or comorbidity count

Main finding

As reported in the abstract

mSASSS progression, mean difference (units/10 years)
Each group vs no comorbiditiesMean difference, units/10 years (95% CI)
Two comorbidities
2.7(1.9–3.5)
Three or more comorbidities
2.3(1.5–3.1)
Uveitis
2.2(1.3–3.0)
Psoriasis
2.4(1.4–3.5)

Observational data: associations, not effects.

Further findings

Sex-specific analyses

Greater spinal progression in females than males with psoriasis

Segment-specific analyses

Cervical-predominant changes with uveitis and psoriasis

Original publication

Impact of comorbidities and extra-musculoskeletal manifestations on radiographic progression in ankylosing spondylitis. Rheumatology (Oxford). Published 9 May 2026. doi:10.1093/rheumatology/keag247

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.